| Profile | GDS1873 / 218357_s_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 2232.62 | 95 |
| GSM40788 | control - Rep 2 | 1620.87 | 94 |
| GSM40789 | control - Rep 3 | 1525.98 | 93 |
| GSM40775 | androgen treated - Rep 1 | 1623.56 | 94 |
| GSM40776 | androgen treated - Rep 2 | 2158.62 | 95 |
| GSM40777 | androgen treated - Rep 3 | 1505.3 | 93 |
| GSM40790 | estrogen treated - Rep 1 | 1762.08 | 94 |
| GSM40791 | estrogen treated - Rep 2 | 1443.57 | 92 |
| GSM40792 | estrogen treated - Rep 3 | 2258.59 | 95 |
| GSM40784 | A + tamoxifen - Rep 1 | 1659.61 | 93 |
| GSM40785 | A + tamoxifen - Rep 2 | 1835.52 | 94 |
| GSM40786 | A + tamoxifen - Rep 3 | 2163.14 | 95 |
| GSM40778 | A + anastrozole - Rep 1 | 1320.4 | 93 |
| GSM40779 | A + anastrozole - Rep 2 | 1967.24 | 94 |
| GSM40780 | A + anastrozole - Rep 3 | 2052.61 | 95 |
| GSM40781 | A + letrozole - Rep 1 | 1618.54 | 94 |
| GSM40782 | A + letrozole - Rep 2 | 1721.01 | 94 |
| GSM40783 | A + letrozole - Rep 3 | 2326.94 | 95 |